company background image
INFU

InfuSystem HoldingsNYSEAM:INFU Stock Report

Market Cap

US$264.9m

7D

-3.1%

1Y

0.2%

Updated

23 Sep, 2021

Data

Company Financials +
INFU fundamental analysis
Snowflake Score
Valuation4/6
Future Growth5/6
Past Performance6/6
Financial Health3/6
Dividends0/6

INFU Overview

InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada.

Price History & Performance

Summary of all time highs, changes and price drops for InfuSystem Holdings
Historical stock prices
Current Share PriceUS$13.13
52 Week HighUS$11.65
52 Week LowUS$23.26
Beta0.88
1 Month Change-13.51%
3 Month Change-26.03%
1 Year Change0.15%
3 Year Change291.94%
5 Year Change380.95%
Change since IPO144.96%

Recent News & Updates

Shareholder Returns

INFUUS HealthcareUS Market
7D-3.1%-1.5%-1.7%
1Y0.2%37.7%36.2%

Return vs Industry: INFU underperformed the US Healthcare industry which returned 37.7% over the past year.

Return vs Market: INFU underperformed the US Market which returned 36.2% over the past year.

Price Volatility

Is INFU's price volatile compared to industry and market?
INFU volatility
INFU Beta0.88
Industry Beta0.87
Market Beta1

Stable Share Price: INFU is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 10% a week.

Volatility Over Time: INFU's weekly volatility (10%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2005287Rich DiIoriohttps://www.infusystem.com

InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates through two segments, Integrated Therapy Services (ITS) and Durable Medical Equipment (DME) Services. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology clinics, infusion clinics, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states.

InfuSystem Holdings Fundamentals Summary

How do InfuSystem Holdings's earnings and revenue compare to its market cap?
INFU fundamental statistics
Market CapUS$264.92m
Earnings (TTM)US$15.09m
Revenue (TTM)US$98.97m

17.9x

P/E Ratio

2.7x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
INFU income statement (TTM)
RevenueUS$98.97m
Cost of RevenueUS$39.39m
Gross ProfitUS$59.59m
ExpensesUS$44.49m
EarningsUS$15.09m

Last Reported Earnings

Jun 30, 2021

Next Earnings Date

n/a

Earnings per share (EPS)0.74
Gross Margin60.20%
Net Profit Margin15.25%
Debt/Equity Ratio72.6%

How did INFU perform over the long term?

See historical performance and comparison

Valuation

Is InfuSystem Holdings undervalued compared to its fair value and its price relative to the market?

>50%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: INFU ($13.13) is trading below our estimate of fair value ($39.72)

Significantly Below Fair Value: INFU is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: INFU is good value based on its PE Ratio (17.9x) compared to the US Healthcare industry average (22x).

PE vs Market: INFU is poor value based on its PE Ratio (17.9x) compared to the US market (17.7x).


Price to Earnings Growth Ratio

PEG Ratio: INFU is good value based on its PEG Ratio (0.8x)


Price to Book Ratio

PB vs Industry: INFU is overvalued based on its PB Ratio (6x) compared to the US Healthcare industry average (3.2x).


Future Growth

How is InfuSystem Holdings forecast to perform in the next 1 to 3 years based on estimates from 4 analysts?

22.2%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: INFU's forecast earnings growth (22.2% per year) is above the savings rate (2%).

Earnings vs Market: INFU's earnings (22.2% per year) are forecast to grow faster than the US market (14.9% per year).

High Growth Earnings: earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: INFU's revenue (12.7% per year) is forecast to grow faster than the US market (9.8% per year).

High Growth Revenue: INFU's revenue (12.7% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: INFU's Return on Equity is forecast to be high in 3 years time (22.5%)


Past Performance

How has InfuSystem Holdings performed over the past 5 years?

50.6%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: INFU has high quality earnings.

Growing Profit Margin: INFU's current net profit margins (15.2%) are higher than last year (6.3%).


Past Earnings Growth Analysis

Earnings Trend: INFU's earnings have grown significantly by 50.6% per year over the past 5 years.

Accelerating Growth: INFU's earnings growth over the past year (166.5%) exceeds its 5-year average (50.6% per year).

Earnings vs Industry: INFU earnings growth over the past year (166.5%) exceeded the Healthcare industry 32.2%.


Return on Equity

High ROE: INFU's Return on Equity (33.8%) is considered high.


Financial Health

How is InfuSystem Holdings's financial position?


Financial Position Analysis

Short Term Liabilities: INFU's short term assets ($21.7M) exceed its short term liabilities ($15.8M).

Long Term Liabilities: INFU's short term assets ($21.7M) do not cover its long term liabilities ($35.4M).


Debt to Equity History and Analysis

Debt Level: INFU's debt to equity ratio (72.6%) is considered high.

Reducing Debt: INFU's debt to equity ratio has increased from 65.5% to 72.6% over the past 5 years.

Debt Coverage: INFU's debt is well covered by operating cash flow (76.5%).

Interest Coverage: INFU's interest payments on its debt are well covered by EBIT (5.2x coverage).


Balance Sheet


Dividend

What is InfuSystem Holdings's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate INFU's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate INFU's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if INFU's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if INFU's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of INFU's dividend in 3 years as they are not forecast to pay a notable one for the US market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

2.0yrs

Average management tenure


CEO

Rich DiIorio (46 yo)

3.83yrs

Tenure

US$3,196,173

Compensation

Mr. Richard A. DiIorio, also known as Rich, joined InfuSystem Holdings Inc. in 2004 and serves as its Chief Executive Officer and Director since November 15, 2017. He served as President at InfuSystem Hold...


CEO Compensation Analysis

Compensation vs Market: Rich's total compensation ($USD3.20M) is above average for companies of similar size in the US market ($USD1.09M).

Compensation vs Earnings: Rich's compensation has increased by more than 20% in the past year.


Leadership Team

Experienced Management: INFU's management team is not considered experienced ( 2 years average tenure), which suggests a new team.


Board Members

Experienced Board: INFU's board of directors are considered experienced (3.8 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

InfuSystem Holdings Inc.'s employee growth, exchange listings and data sources


Key Information

  • Name: InfuSystem Holdings Inc.
  • Ticker: INFU
  • Exchange: NYSEAM
  • Founded: 2005
  • Industry: Health Care Services
  • Sector: Healthcare
  • Market Cap: US$264.922m
  • Shares outstanding: 20.57m
  • Website: https://www.infusystem.com

Number of Employees


Location

  • InfuSystem Holdings Inc.
  • 3851 West Hamlin Road
  • Rochester Hills
  • Michigan
  • 48309
  • United States

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/09/23 23:03
End of Day Share Price2021/09/23 00:00
Earnings2021/06/30
Annual Earnings2020/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.